[PDF][PDF] Arterial chemotherapy of oxaliplatin plus fluorouracil versus sorafenib in advanced hepatocellular carcinoma: a biomolecular exploratory, randomized, phase III …
N Lyu, X Wang, JB Li, JF Lai, QF Chen… - Journal of Clinical …, 2022 - drive.google.com
METHODS In this open-label, phase III trial, patients with advanced HCC, previously
untreated with systemic therapy, were randomly assigned in a 1: 1 ratio to receive HAIC-FO …
untreated with systemic therapy, were randomly assigned in a 1: 1 ratio to receive HAIC-FO …
Prediction of therapeutic response of unresectable hepatocellular carcinoma to hepatic arterial infusion chemotherapy based on pretherapeutic MRI radiomics and …
Y Zhao, F Huang, S Liu, L Jian, X Xia, H Lin… - Journal of Cancer …, 2023 - Springer
Purpose To construct and validate a combined nomogram model based on magnetic
resonance imaging (MRI) radiomics and Albumin-Bilirubin (ALBI) score to predict …
resonance imaging (MRI) radiomics and Albumin-Bilirubin (ALBI) score to predict …
Automatic prediction of hepatic arterial infusion chemotherapy response in advanced hepatocellular carcinoma with deep learning radiomic nomogram
Z Xu, C An, F Shi, H Ren, Y Li, S Chen, J Dou… - European …, 2023 - Springer
Objectives Hepatic arterial infusion chemotherapy (HAIC) using the FOLFOX regimen
(oxaliplatin plus fluorouracil and leucovorin) is a promising option for advanced …
(oxaliplatin plus fluorouracil and leucovorin) is a promising option for advanced …
DEB-TACE combined with hepatic artery infusion chemotherapy might be an affordable treatment option for advanced stage of HCC
Y Kondo, T Morosawa, S Minami, Y Tanaka - Scientific Reports, 2022 - nature.com
Alternative treatment modalities are necessary because of the low response rates and
unsuitability of molecular-targeted agents (MTA) and/or immune checkpoint inhibitors (iCIs) …
unsuitability of molecular-targeted agents (MTA) and/or immune checkpoint inhibitors (iCIs) …
Cost-effectiveness and prognostic model of hepatic arterial infusion chemotherapy for hepatocellular carcinoma with high tumor burden and/or Vp4 tumor thrombus …
QF Chen, N Lyu, X Wang, XY Jiang, Y Hu… - … Journal of Surgery, 2023 - journals.lww.com
Objectives: The phase III FOHAIC-1 trial revealed that hepatic arterial infusion of
chemotherapy (HAIC) improved overall survival compared to sorafenib in the high-risk …
chemotherapy (HAIC) improved overall survival compared to sorafenib in the high-risk …
中晚期肝细胞癌的局部治疗联合系统治疗研究进展.
曹白露， 艾敏， 黄平， 杨永峰 - Journal of Clinical Hepatology …, 2023 - search.ebscohost.com
曹白露,艾敏,黄平,杨永峰 Page 1 , DOI:10. 3969 / j. issn. 1001 r 5256. 2023. 08. 031 中晚期肝细胞
癌的局部治疗联合系统治疗研究进展 曹白露,艾敏,黄平,杨永峰 南京中医药大学附属南京医院(南京 …
癌的局部治疗联合系统治疗研究进展 曹白露,艾敏,黄平,杨永峰 南京中医药大学附属南京医院(南京 …
Research advances in local treatment combined with systemic therapy for advanced hepatocellular carcinoma
CAO Bailu, AI Min, P HUANG - 临床肝胆病杂志, 2023 - lcgdbzz.org
Most patients with hepatocellular carcinoma (HCC) have reached the advanced stage at the
time of diagnosis in China, and a single treatment regimen tends to have a low objective …
time of diagnosis in China, and a single treatment regimen tends to have a low objective …
Short Half-Life of Des-γ-Carboxy Prothrombin Is a Superior Factor for Early Prediction of Outcomes of Hepatocellular Carcinoma Treated with Radiofrequency Ablation
CC Yao, JH Wang, CH Chen, CH Hung, YH Yen… - Diagnostics, 2023 - mdpi.com
Background: The role of des-γ-carboxy prothrombin (DCP) in patients undergoing
radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) needs to be clarified …
radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) needs to be clarified …
DEB-TACE Combined With Hepatic Artery Infusion Chemotherapy Might Be an Affordable Treatment Option for Advanced Stage of HCC: Retrospective Study
Y Kondo, T Morosawa, S Minami, Y Tanaka - 2022 - researchsquare.com
Methods From November 2017 to April 2021, 118 consecutive patients with non-resectable
difficult-to-treat HCC were included in this study. All patients were treated with Ultra-FP …
difficult-to-treat HCC were included in this study. All patients were treated with Ultra-FP …